EODData

MEMBERSHIP REGISTER LOG IN

FRA, AYJ: Valneva SE

05 Nov 2025
LAST:

3.888

CHANGE:
 0.08		OPEN:
3.952		HIGH:
3.952		ASK:
0.000		VOLUME:
700
CHG(%):
2.02		PREV:
3.968		LOW:
3.888		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Nov 253.9523.9523.8883.888700
04 Nov 253.9964.0023.9683.96811.2K
03 Nov 254.0044.0103.8903.89819.3K
31 Oct 253.9664.0983.9664.05811.9K
30 Oct 253.8824.0183.8823.9982.7K
29 Oct 253.8323.9783.8323.9783.6K
28 Oct 253.9283.9763.8663.8666.6K
27 Oct 254.0824.0823.9063.90611.0K
24 Oct 254.1064.1064.0304.030660
23 Oct 254.1384.1444.1104.14422

COMPANY PROFILE

Name:Valneva SE
About:Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, a diarrheal infection caused by Shigella bacteria; VLA1601, a vaccine candidate targeting the Zika virus, a mosquito-borne viral disease; VLA1554, a vaccine candidate targeting human metapneumovirus; VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. The company was founded in 1998 and is based in Saint-Herblain, France.
Sector:Healthcare
Industry:Biotechnology
Address:6 rue Alain Bombard, Saint-Herblain, France, 44800
Website:https://valneva.com
ISIN:FR0004056851

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:74.00 
Forward P/E:625.00 
Price to Sales:3.41 
Price to Book:3.48 
Profit Margin:-0.34 
Operating Margin:-0.22 
Return on Assets:-0.07 
Return on Equity:-0.38 
Revenue:196.33M 
EBITDA:35.01M 
Shares:170.06M 
Market Cap:661.21M 

TECHNICAL INDICATORS

MA5:3.961.9%
MA10:3.972.2%
MA20:4.187.6%
MA50:4.187.5%
MA100:3.714.9%
MA200:3.3815.1%
STO9:9.17 
STO14:4.31 
RSI14:28.44 
WPR14:-95.53 
MTM14:-0.47
ROC14:-0.11 
ATR:0.13 
Week High:4.105.4%
Week Low:3.831.5%
Month High:4.8925.9%
Month Low:3.8315.1%
Year High:5.3036.3%
Year Low:1.75121.8%
Volatility:55.08 

RECENT SPLITS

Date Ratio
15 Jan 20151201-1083
17 Jun 20131874-1675
05 Jul 2010757-671